Achilles therapeutics announces grant of us patent on immunotherapies targeting clonal neoantigens identified using proprietary method

- us patent is for an immunotherapy targeting clonal neoantigens identified by the achilles clonality engine (ace), including vaccine, antibody, and autologous t cell therapy approaches - - us patent is for an immunotherapy targeting clonal neoantigens identified by the achilles clonality engine (ace), including vaccine, antibody, and autologous t cell therapy approaches -
ACHL Ratings Summary
ACHL Quant Ranking